NCT04467411View on ClinicalTrials.gov

The EMBRACE Study The EMBRACE Study

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

August 30, 2030

Study Completion Date

August 30, 2030

Conditions
Breast Cancer
Trial Locations (1)

AB25 2ZD

RECRUITING

Cardiovascular Research Facility, Aberdeen

All Listed Sponsors
lead

University of Aberdeen

OTHER

NCT04467411 - The EMBRACE Study The EMBRACE Study | Biotech Hunter | Biotech Hunter